Celgene Corporation
CELGENE CORP /DE/ (Form: 4, Received: 02/10/2015 18:47:06)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Alles Mark J
2. Issuer Name and Ticker or Trading Symbol

CELGENE CORP /DE/ [ CELG ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
See Remarks
(Last)          (First)          (Middle)

C/O CELGENE CORPORATION, 86 MORRIS AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

2/6/2015
(Street)

SUMMIT, NJ 07901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   2/6/2015     M    4922   A $81.555   71064   D    
Common Stock   2/6/2015     M    4434   A $74.30   75498   D    
Common Stock   2/6/2015     M    1719   A $27.275   77217   D    
Common Stock   2/6/2015     M    444   A $30.74   77661   D    
Common Stock   2/6/2015     M    1290   A $26.17   78951   D    
Common Stock   2/6/2015     M    2580   A $28.94   81531   D    
Common Stock   2/6/2015     M    41335   A $29.75   122866   D    
Common Stock   2/6/2015     M    1290   A $25.765   124156   D    
Common Stock   2/6/2015     M    4688   A $36.96   128844   D    
Common Stock   2/6/2015     M    3122   A $36.465   131966   D    
Common Stock   2/6/2015     M    6243   A $34.70   138209   D    
Common Stock   2/6/2015     M    6243   A $36.675   144452   D    
Common Stock   2/6/2015     M    13125   A $40.22   157577   D    
Common Stock   2/6/2015     M    3122   A $49.475   160699   D    
Common Stock   2/6/2015     M    4434   A $59.235   165133   D    
Common Stock   2/6/2015     M    4434   A $71.33   169567   D    
Common Stock   2/6/2015     M    4434   A $78.115   174001   D    
Common Stock   2/6/2015     S    117099   D $120.677   (1) 56902   D    
Common Stock   2/6/2015     A    30404   (2) A $0.00   87306   D    
Common Stock   2/6/2015     F    13666   D $118.75   73640   D    
Common Stock                  5461   I   401(k) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $81.555   2/6/2015     M         4922      (3) 12/2/2023   Common Stock   4922   $0.00   (4) 14764   D    
Stock Option (right to buy)   $74.30   2/6/2015     M         4434      (3) 2/3/2024   Common Stock   4434   $0.00   (4) 13302   D    
Stock Option (right to buy)   $27.275   2/6/2015     M         1719      (3) 10/13/2019   Common Stock   1719   $0.00   (4) 573   D    
Stock Option (right to buy)   $30.74   2/6/2015     M         444      (3) 4/13/2020   Common Stock   444   $0.00   (4) 148   D    
Stock Option (right to buy)   $26.17   2/6/2015     M         1290      (3) 7/13/2020   Common Stock   1290   $0.00   (4) 430   D    
Stock Option (right to buy)   $28.94   2/6/2015     M         2580      (3) 10/12/2020   Common Stock   2580   $0.00   (4) 860   D    
Stock Option (right to buy)   $29.75   2/6/2015     M         41335      (3) 12/27/2020   Common Stock   41335   $0.00   (4) 5333   D    
Stock Option (right to buy)   $25.765   2/6/2015     M         1290      (3) 1/31/2021   Common Stock   1290   $0.00   (4) 430   D    
Stock Option (right to buy)   $36.96   2/6/2015     M         4688      (3) 3/1/2022   Common Stock   4688   $0.00   (4) 9852   D    
Stock Option (right to buy)   $36.465   2/6/2015     M         3122      (3) 4/30/2022   Common Stock   3122   $0.00   (4) 9366   D    
Stock Option (right to buy)   $34.70   2/6/2015     M         6243      (3) 7/30/2022   Common Stock   6243   $0.00   (4) 10407   D    
Stock Option (right to buy)   $36.675   2/6/2015     M         6243      (3) 10/31/2022   Common Stock   6243   $0.00   (4) 10407   D    
Stock Option (right to buy)   $40.22   2/6/2015     M         13125      (3) 12/17/2022   Common Stock   13125   $0.00   (4) 21875   D    
Stock Option (right to buy)   $49.475   2/6/2015     M         3122      (3) 1/28/2023   Common Stock   3122   $0.00   (4) 11508   D    
Stock Option (right to buy)   $59.235   2/6/2015     M         4434      (3) 4/29/2023   Common Stock   4434   $0.00   (4) 19216   D    
Stock Option (right to buy)   $71.33   2/6/2015     M         4434      (3) 7/29/2023   Common Stock   4434   $0.00   (4) 13302   D    
Stock Option (right to buy)   $78.115   2/6/2015     M         4434      (3) 10/28/2023   Common Stock   4434   $0.00   (4) 13302   D    

Explanation of Responses:
( 1)  The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person pursuant to a rule 10b5-1 plan in multiple transactions at prices ranging from $118.98 to $121.70, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
( 2)  Represents shares of common stock relating to the 2012-2014 Long Term Incentive Plan and issued under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).
( 3)  The option was fully exercisable.
( 4)  The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).

Remarks:
President and Chief Operating Officer

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Alles Mark J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT, NJ 07901


See Remarks

Signatures
/s/ Robert J. Hugin __________________________ Robert J. Hugin, Attorney-in-Fact 2/10/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.